Reata Pharmaceuticals Inc

RHUMBLINE ADVISERS

Report date

6/30/2023

Quarter

2023 Q2

Filed

8/8/2023

Shares

48,033

Value ($000)

4,897

Weight

0.0%

2019 Q4 - 2023 Q2 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	8/8/2023	4,897	0.0%	48,033	6/30/2023
2023 Q1	5/11/2023	3,674	0.0%	40,408	3/31/2023
2022 Q4	2/14/2023	1,480	0.0%	38,952	12/31/2022
2022 Q3	11/10/2022	958	0.0%	38,112	9/30/2022
2022 Q2	8/11/2022	1,059	0.0%	34,845	6/30/2022
2022 Q1	5/12/2022	982	0.0%	29,981	3/31/2022
2021 Q4	2/10/2022	792	0.0%	30,046	12/31/2021
2021 Q3	11/12/2021	3,062	0.0%	30,437	9/30/2021
2021 Q2	8/5/2021	4,270	0.0%	30,169	6/30/2021
2021 Q1	5/6/2021	2,531	0.0%	25,390	3/31/2021
2020 Q4	2/10/2021	3,209	0.0%	25,959	12/31/2020
2020 Q3	11/12/2020	2,529	0.0%	25,960	9/30/2020
2020 Q2	8/13/2020	4,340	0.0%	27,817	6/30/2020
2020 Q1	5/6/2020	5,520	0.0%	38,246	3/31/2020
2019 Q4	2/5/2020	7,178	0.0%	35,112	12/31/2019